If you've ever tried discussing medicines with friends or family and found yourself stumbling over the pronunciation - or ...

Reports Continued Progress Across Both Obesity and Oncology FranchisesHOUSTON, March 28, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (OTCQB:BPTH), a biotechnology company leveraging its ...

Its intermediate products include glibenclamde sulphonamide, cis-bramo benzoate, cls-tosylate, 2-ethoxy benzoic acid, 2-ethoxy benzoic acid, among others. It offers its manufacturing and technical ...

Names like idarucizumab, levetiracetam and ustekinumab may look like words from Greek or Norse mythology, but they're chosen ...

StockNews.com began coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research note released on Wednesday morning. The brokerage issued a sell rating on the stock. Bio-Path Stock Down 5.

DMG-PEG-Dopamine（1,2-二肉豆蔻酰-SN-甘油-聚乙二醇-多巴胺）是一种多功能的化合物，结合了脂质部分（DMG）、亲水性PEG链段和具有生物活性的多巴胺基团。 1,2-二肉豆蔻酰-SN-甘油（DMG）：提供脂质特性，能够与细胞膜的脂质双层相互作用，增强细胞摄取。 聚乙二醇 ...

DMG-PEG-Dopamine（1,2-二肉豆蔻酰-SN-甘油-聚乙二醇-多巴胺）是一种多功能的化合物，结合了脂质部分（DMG）、亲水性PEG链段和具有生物活性的多巴胺基团。 1,2-二肉豆蔻酰-SN-甘油（DMG）：提供脂质特性，能够与细胞膜的脂质双层相互作用，增强细胞摄取。 聚乙二醇 ...

Bio-Path received Notice of Allowance from the United States Patent and Trademark Office for U.S. Patent No. 17/339,366 titled, “P-ethoxy nucleic acids for STAT3 inhibition.” The New Zealand ...

Bio-Path Holdings, Inc., (OTCQB:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio ...

If you've ever tried discussing medicines with friends or family and found yourself stumbling over the pronunciation - or even resorting to snapping a ...

Instituto de Química, Universidade de São Paulo, São Paulo 05513-970, Brazil ...